Drinking excessive amounts of alcohol this holiday may not make you an addict—according to a recent CDC report on the diagnostic criteria for alcoholism—but it will significantly damage your body. Dennis Dimitri, MD, explains the adverse effects of binge drinking in this Expert’s Corner.
UMass Medical School is involved in a new initiative, led by Diagnostics For All, to develop a rapid diagnostic test for Ebola. Such testing will make a ‘huge difference,’ according to Ebola survivor and physician Rick Sacra, who spoke at the State House press conference about the project.
Phillip D. Zamore, PhD, a pioneer in the study of RNA silencing, was named a 2014 Fellow of the National Academy of Inventors, a high professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation.
MassBiologics of UMass Medical School and Voyager Therapeutics will collaborate on viral vector manufacturing at the new MassBiologics SouthCoast facility in Fall River.
A 60 Minutes report on mindfulness meditation features interviews with UMass Medical School’s Center for Mindfulness founder Jon Kabat-Zinn, PhD, and current faculty Judson Brewer, MD, PhD, and Jean King, PhD.
Infectious disease expert Robert Finberg, MD, said it is too early to predict whether Massachusetts will experience a severe flu season this year and urged families to get the vaccine.
While UMass Medical School psychiatrist Anthony Rothschild, MD, acknowledges that there is an urgent need for new antidepressant medications, he is cautious about the rising use of ketamine as a treatment for depression, as he told the New York Times for a Dec. 19 feature on the promising but controversial drug.
Two newly endowed chairs were approved by the university’s Board of Trustees, according to Chancellor Michael F. Collins. Katherine F. Ruiz de Luzuriaga, MD, was named the inaugural recipient of the UMass Memorial Health Care Chair in Biomedical Research. Gyongyi Szabo, MD, PhD, was named the inaugural recipient of the second Worcester Foundation for Biomedical Research Chair.
Renowned depression treatment and psychopharmacology expert Anthony Rothschild, MD, is an investigator for a new clinical trial to determine if a test of an individual patient’s genes will improve antidepressant prescribing decisions and patient outcomes.
A new report from the Centers for Disease Control finds that 55 percent of infants are put to bed in unsafe sleep environments. In this Expert’s Corner video, UMass Medical School’s Linda Sagor, MD, MPH, explains the dangers and how to keep babies sleeping safely.